291 related articles for article (PubMed ID: 22814353)
1. Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study.
Piloya T; Bakeera-Kitaka S; Kekitiinwa A; Kamya MR
J Int AIDS Soc; 2012 Jul; 15(2):17427. PubMed ID: 22814353
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children.
Sánchez Torres AM; Munoz Muniz R; Madero R; Borque C; García-Miguel MJ; De José Gómez MI
Eur J Pediatr; 2005 May; 164(5):271-6. PubMed ID: 15650834
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
4. Lipodystrophy and metabolic complications of highly active antiretroviral therapy.
Parakh A; Dubey AP; Kumar A; Maheshwari A
Indian J Pediatr; 2009 Oct; 76(10):1017-21. PubMed ID: 19907933
[TBL] [Abstract][Full Text] [Related]
5. Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India.
Bhutia E; Hemal A; Yadav TP; Ramesh KL
Afr Health Sci; 2014 Jun; 14(2):408-13. PubMed ID: 25320591
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe.
European Paediatric Lipodystrophy Group
AIDS; 2004 Jul; 18(10):1443-51. PubMed ID: 15199321
[TBL] [Abstract][Full Text] [Related]
7. Lipodystrophy syndrome in human immunodeficiency virus-infected children.
Amaya RA; Kozinetz CA; McMeans A; Schwarzwald H; Kline MW
Pediatr Infect Dis J; 2002 May; 21(5):405-10. PubMed ID: 12150177
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
Bwakura-Dangarembizi M; Musiime V; Szubert AJ; Prendergast AJ; Gomo ZA; Thomason MJ; Musarurwa C; Mugyenyi P; Nahirya P; Kekitiinwa A; Gibb DM; Walker AS; Nathoo K;
Pediatr Infect Dis J; 2015 Feb; 34(2):e23-31. PubMed ID: 25068287
[TBL] [Abstract][Full Text] [Related]
9. Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens.
Taylor P; Worrell C; Steinberg SM; Hazra R; Jankelevich S; Wood LV; Zwerski S; Yarchoan R; Zeichner S
Pediatrics; 2004 Aug; 114(2):e235-42. PubMed ID: 15286262
[TBL] [Abstract][Full Text] [Related]
10. Non-traditional adipokines in pediatric HIV-related lipodystrophy: a-FABP as a biomarker of central fat accumulation.
Theodoridou K; Margeli A; Spoulou V; Bathrellou I; Skevaki C; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
Scand J Clin Lab Invest; 2014 Jan; 74(1):67-73. PubMed ID: 24266781
[TBL] [Abstract][Full Text] [Related]
11. Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.
Mandal A; Mukherjee A; Lakshmy R; Kabra SK; Lodha R
Indian J Pediatr; 2016 Mar; 83(3):226-31. PubMed ID: 26334860
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy.
Kinabo GD; Sprengers M; Msuya LJ; Shayo AM; van Asten H; Dolmans WM; van der Ven AJ; Warris A
Pediatr Infect Dis J; 2013 Jan; 32(1):39-44. PubMed ID: 23038217
[TBL] [Abstract][Full Text] [Related]
13. Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.
Mercier S; Gueye NF; Cournil A; Fontbonne A; Copin N; Ndiaye I; Dupuy AM; Cames C; Sow PS; Ndoye I; Delaporte E; Simondon KB
J Acquir Immune Defic Syndr; 2009 Jun; 51(2):224-30. PubMed ID: 19339897
[TBL] [Abstract][Full Text] [Related]
14. COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort.
Mayanja BN; Kasamba I; Levin J; Namakoola I; Kazooba P; Were J; Kaleebu P; Munderi P;
AIDS Res Ther; 2017; 14():26. PubMed ID: 28484508
[TBL] [Abstract][Full Text] [Related]
15. Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study.
Guaraldi G; Zona S; Orlando G; Carli F; Stentarelli C; Luzi K; Garlassi E; Menozzi M; Bagni P; Adorni F
Clin Drug Investig; 2011 Nov; 31(11):759-67. PubMed ID: 21919542
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in estrogen receptors and sexual dimorphism in fat redistribution in HIV-infected patients on HAART.
Gasparotto AS; Sprinz E; Lazzaretti RK; Kuhmmer R; Silveira JM; Basso RP; Pinheiro CA; Silveira MF; Ribeiro JP; Mattevi VS
AIDS; 2012 Jan; 26(1):19-26. PubMed ID: 22011627
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study.
Ene L; Goetghebuer T; Hainaut M; Peltier A; Toppet V; Levy J
Eur J Pediatr; 2007 Jan; 166(1):13-21. PubMed ID: 16896646
[TBL] [Abstract][Full Text] [Related]
18. Association between changes in body fat distribution, biochemical profile, time of HIV diagnosis, and antiretroviral treatment in adults living with and without virus infection.
Soares LR; Menezes GC; Barreto APM; Sant'Anna MSL; Cardoso NMA; Casseb JSDR; Fonseca FLA
Rev Assoc Med Bras (1992); 2020; 66(1):67-73. PubMed ID: 32130384
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of lipodystrophy and metabolic syndrome among HIV positive individuals on Highly Active Anti-Retroviral treatment in Jimma, South West Ethiopia.
Berhane T; Yami A; Alemseged F; Yemane T; Hamza L; Kassim M; Deribe K
Pan Afr Med J; 2012; 13():43. PubMed ID: 23330034
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy.
Spoulou V; Kanaka-Gantenbein C; Bathrellou I; Mora S; Mostrou G; Sidossis L; Chrousos G; Theodoridou M
Hormones (Athens); 2011; 10(2):149-55. PubMed ID: 21724540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
